Hansmann et al 1 Hansmann J. Kuei A. Patel M.N. Albright W. Bui J.T. Williams D. et al. Evaluation of a clinical decision support tool to predict permanence of retrievable inferior vena cava filters.

J Vasc Surg Venous Lymphat Disord. 2022; 10: 894-899

reported their validity assessment of a previously reported model that estimates the likelihood of safe removal of a retrievable inferior vena cava filter (rIVCF). In 2010, the Food and Drug Administration delivered safety communications stating that ongoing surveillance and management of rIVCF was the responsibility of the treating and implanting clinicians and that, once no longer needed, retrieval should be considered. 2 Safety Communications
Removing retrievable inferior vena cava filters: FDA safety communication. This resulted in decreased usage of rIVCFs throughout the United States. 3 Wadhwa V. Ahmed O. Lessne M.L. Ryu R.K. Trivedi P.S. Continued decrease in utilization of IVC filters: update from 2016 Nationwide Inpatient Sample.

Clin Imaging. 2020; 65: 94-95